High serum Ephrin-B2 levels predict poor prognosis for patients with gastric cancer

Gastric cancer is an intractable disease with a poor prognosis and limited treatment options. Its treatment remains a major clinical challenge worldwide. Ephrin-B2 is upregulated and involved in tumor growth in various types of cancer. However, the association between ephrin-B2 and prognosis of gast...

Descripción completa

Detalles Bibliográficos
Autores principales: Yue, Wen-Jing, Liu, Yi-Pin, Li, Ming, Liu, Cheng-Xia, Mou, Shao-Jia, Li, Qian-Kun, Chen, Zi-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126187/
https://www.ncbi.nlm.nih.gov/pubmed/30214580
http://dx.doi.org/10.3892/ol.2018.9202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126187/
https://www.ncbi.nlm.nih.gov/pubmed/30214580
http://dx.doi.org/10.3892/ol.2018.9202

Ejemplares similares